Evidence map›Paper›PMID 40786509›Full record

ArticleFrontiers in oncology2025

Global burden and cross-national inequalities of tobacco-attributable cancers in adults aged 40 and above, 1990-2021: a population-based study.

Yi Li, Hui Li, Lirui Tang, Chuanben Chen, Chaoxiong Huang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yi Li *Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Hui Li *Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Lirui TangDepartment of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chuanben ChenDepartment of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Chaoxiong HuangDepartment of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tobacco exposure substantially increases the global cancer burden; however, studies targeting specific subgroups are scarce. We aimed to investigate global burden trends of tobacco-attributable cancers among people aged ≥40 and the associated cross-national inequalities based on the sociodemographic index (SDI). Methods: We performed secondary analyses on data from the Global Burden of Disease (GBD) Study 2021. The global tobacco-attributable cancer burden was assessed by age-standardized (ASR)-disability adjusted life years (DALYs) and deaths. The estimated annual percentage changes were used to illustrate temporal global and regional trends from 1990 to 2021. Decomposition analyses determined the impact of population growth, aging, and epidemiological changes on disease burden. The slope inequality index (SII) and concentration index (CI) were used to quantify cross-country inequalities in the tobacco-attributable cancer burden. Results: In 2021, global tobacco-attributable ASR-DALYs among people aged ≥40 were 1,687.49 per 100,000 people, a continuous decline since 1990, and ASR deaths were 72.36 per 100,000 people. By 2030, they are projected to fall to 1,464.68 and 64.59 per 100,000, respectively. Men exhibited higher DALYs and deaths than women (40.8 million DALYs, 1.7 million deaths). The most prominent tobacco exposure was smoking (ASR-DALY: 1,603.98/100000). Among the 16 cancers observed, tracheal, bronchial, and lung cancers had significantly higher ASR-DALYs and ASR-related deaths than other cancers. Population growth was the main cause of the tobacco-attributable cancer burden, followed by epidemiological changes. The highest ASR-DALYs and deaths were observed in the medium-high SDI regions and the lowest in the low SDI regions. Health inequality analyses showed that the DALYs SII declined from 2,654/100,000 in 1990 to 1,178/100,000 in 2021; however, the difference between high and low SDI countries narrowed significantly. The DALYs CI was 0.17 in 1990 and 2021, and the mortality CI increased from 0.17 to 0.18. Conclusions: The cancer burden attributable to tobacco use varied significantly according to sex, age, region, and SDI. The global tobacco-attributable cancer burden among people aged ≥40 has been declining since 1990, paralleling mitigated yet persistent cross-national inequalities. The study's findings could help to develop strategies for improving the prevention and treatment of cancers.

Indexed as

cancer burdencrossnational inequalitiesdeathsdisability adjusted Life Years (DALYs)global burden of disease (GBD) studysociodemographic index (SDI)tobacco exposure

Identifiers

PMID40786509
PMCPMC12331488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.